131
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Sustained-release of erythropoietin using a novel injectable thermosensitive hydrogel: in vitro studies, biological activity, and efficacy in rats

, , ORCID Icon, &
Pages 412-421 | Received 14 Jul 2020, Accepted 26 Jan 2021, Published online: 10 Feb 2021

References

  • Ahmed E. 2015. Hydrogel: preparation, characterization, and applications: a review. J Adv Res. 6(2):105–121.
  • Akbari V, Rezazadeh M, Minayian M, Amirian M, Moghadas A, Talebi A. 2018. Effect of freeze drying on stability, thermo-responsive characteristics, and in vivo wound healing of erythropoietin-loaded trimethyl chitosan/glycerophosphate hydrogel. Res Pharm Sci. 13(6):476–483.
  • Bulmer C, Margaritis A, Xenocostas A. 2012. Production and characterization of novel chitosan nanoparticles for controlled release of rHu-erythropoietin. Biochem Eng J. 68:61–69.
  • Cazzola M, Ponchio L, Beguin Y, Rosti V, Bergamaschi G, Liberato NL, Fregoni V, Nalli G, Barosi G, Ascari E, et al. 1992. Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood. 79(1):29–37.
  • Dara T, Vatanara A, Nabi Meybodi M, Vakilinezhad MA, Malvajerd SS, Vakhshiteh F, Shamsian A, Sharifzadeh M, Kaghazian H, Mosaddegh MH, et al. 2019. Erythropoietin-loaded solid lipid nanoparticles: preparation, optimization, and in vivo evaluation. Colloids Surf B Biointerfaces. 178:307–316.
  • Eschbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW. 1989. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med. 321(3):158–163.
  • Fayed B, Tawfik A, Yassin A. 2012. Novel erythropoietin-loaded nanoparticles with prolonged in vivo response. J Microencapsul. 29(7):650–656.
  • Geng Y, Yuan W, Wu F, Chen J, He M, Jin T. 2008. Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregation. J Control Release. 130(3):259–265.
  • Hahn SK, Oh EJ, Miyamoto H, Shimobouji T. 2006. Sustained release formulation of erythropoietin using hyaluronic acid hydrogels crosslinked by Michael addition. Int J Pharm. 322(1-2):44–51.
  • Hariyadi DM, Purwanti T, Adilla S. 2018. Influence of crosslinker concentration on the characteristics of erythropoietin-alginate microspheres. J Pharm Pharmacogn Res. 6:250–259.
  • He J, Feng M, Zhou X, Ma S, Jiang Y, Wang Y, Zhang H. 2011. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer. Int J Pharm. 416(1):69–76.
  • Hirakura T, Yasugi K, Nemoto T, Sato M, Shimoboji T, Aso Y, Morimoto N, Akiyoshi K. 2010. Hybrid hyaluronan hydrogel encapsulating nanogel as a protein nanocarrier: new system for sustained delivery of protein with a chaperone-like function. J Control Release. 142(3):483–489.
  • Jardim KV, Joanitti GA, Azeved RB, Parize AL. 2015. Physico-chemical characterization and cytotoxicity evaluation of curcumin loaded in chitosan/chondroitin sulfate nanoparticles. Mater Sci Eng. 56:294–304.
  • Jung Y, Park W, Park H, Lee D, Na K. 2017. Thermo-sensitive injectable hydrogel based on the physical mixing of hyaluronic acid and Pluronic F-127 for sustained NSAID delivery. Carbohydr Polym. 156:403–408.
  • Kobayashi H, Minatoguchi S, Yasuda S, Bao N, Kawamura I, Iwasa M, Yamaki T, Sumi S, Misao Y, Ushikoshi H, et al. 2008. Post-infarct treatment with an erythropoietin–gelatin hydrogel drug delivery system for cardiac repair. Int Cardiovasc Res J. 79(4):611–620.
  • Lee DE, Son W, Ha BJ, Oh MS, Yoo OJ. 2006. The prolonged half-lives of new erythropoietin derivatives via peptide addition. Biochem Biophys Res Commun. 339(1):380–385.
  • Morlock M, Koll H, Winter G, Kissel T. 1997. Microencapsulation of rh-erythropoietin, using biodegradable poly(dl,-lactide-co-glycolide): protein stability and the effects of stabilizing excipients. Eur J Pharm Biopharm. 43(1):29–36.
  • Motokawa K, Kwang S, Teruo H, Hajime N, Tsuyoshi M. 2006. Selectively crosslinked hyaluronic acid hydrogels for sustained release formulation of erythropoietin. J Biomed Mater Res A. 78(3):459–465.
  • Park KM, Lee SY, Joung YK, Na JS, Lee MC, Park KD. 2009. Thermosensitive chitosan-pluronic hydrogel as an injectable cell delivery carrier for cartilage regeneration. Acta Biomater. 5(6):1956–1965.
  • Qi C, Chen Y, Jing Q, Wang X. 2011. Preparation and characterization of catalase-loaded solid lipid nanoparticles protecting enzyme against proteolysis. Int J Mol Sci. 12(7):4282–4293.
  • Ramos AS, Schmidt CA, Andrade SS, Fronza M, Rafferty B, Dalmora SL. 2003. Biological evaluation of recombinant human erythropoietin in pharmaceutical products. Braz J Med Biol Res. 36(11):1561–1569.
  • Rezazadeh M, Akbari V, Amuaghae E, Emami J. 2018. Preparation and characterization of an injectable thermosensitive hydrogel for simultaneous delivery of paclitaxel and doxorubicin. Res Pharm Sci. 13(3):181–191.
  • Rezazadeh M, Parandeh M, Akbari V, Ebrahimi Z, Taheri A. 2019. Incorporation of rosuvastatin-loaded chitosan/chondroitin sulfate nanoparticles into a thermosensitive hydrogel for bone tissue engineering: preparation, characterization, and cellular behavior. Pharm Dev Technol. 24(3):357–367.
  • Rezazadeh M, Jafari N, Akbari V, Amirian M, Tabbakhian M, Minaiyan M, Rostami M. 2018. A mucoadhesive thermosensitive hydrogel containing erythropoietin as a potential treatment in oral mucositis: in vitro and in vivo studies. Drug Deliv Transl Res. 8(5):1226–1237.
  • Slyusareva E, Gerasimova M, Plotnikov CA, Sizykh A. 2014. Spectral study of fluorine dyes adsorption on chitosan based polyelectrolyte complexes. J Colloid Interface Sci. 417:80–87.
  • Wang Y, Cooke MJ, Morshead CM, Shoichet MS. 2012. Hydrogel delivery of erythropoietin to the brain for endogenous stem cell stimulation after stroke injury. Biomaterials. 33(9):2681–2692.
  • Wang YJ, Hao SJ, Liu YD, Hu T, Zhang GF, Zhang X, Qi QS, Ma GH, Su ZG. 2010. PEGylation markedly enhances the in vivo potency of recombinant human non-glycosylated erythropoietin: a comparison with glycosylated erythropoietin. J Control Release. 145(3):306–313.
  • Wang T, Hu Y, Leach MK, Zhang L, Yang W, Jiang L, Feng ZQ, He N. 2012. Erythropoietin-loaded oligochitosan nanoparticles for treatment of periventricular leukomalacia. Int J Pharm. 422(1-2):462–447.
  • Zale S, Burke P, Bernstein H, Brickner A, inventors. 1998. Composition for sustained release of non-aggregated erythropoietin. United States patent US5716644A.
  • Zelikin A, Ehrhardt C, Healy A. 2016. Materials and methods for delivery of biological drugs. Nat Chem. 8(11):997–1007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.